FO
FT Options Portfolio holdings
AUM
$40M
This Quarter Return
+16.05%
1 Year Return
+13.03%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$81.2M
AUM Growth
+$81.2M
(+8.2%)
Cap. Flow
-$1.5M
Cap. Flow
% of AUM
-1.85%
Top 10 Holdings %
Top 10 Hldgs %
49.87%
Holding
239
New
39
Increased
22
Reduced
22
Closed
43
Top Buys
| 1 |
Procter & Gamble
PG
|
$3.95M |
| 2 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$2.38M |
| 3 |
Bristol-Myers Squibb
BMY
|
$2.07M |
| 4 |
iShares Biotechnology ETF
IBB
|
$2.03M |
| 5 |
MON
Monsanto Co
MON
|
$1.77M |
Top Sells
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
$7.18M |
| 2 |
Cal-Maine
CALM
|
$3.64M |
| 3 |
Biogen
BIIB
|
$3.54M |
| 4 |
Apple
AAPL
|
$2.93M |
| 5 |
ALR
Alere Inc
ALR
|
$2.22M |
Sector Composition
| 1 | Healthcare | 62.1% |
| 2 | Consumer Staples | 8.9% |
| 3 | Consumer Discretionary | 8% |
| 4 | Technology | 5.2% |
| 5 | Materials | 4.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Regeneron Pharmaceuticals
REGN
$61.5B
| $10.9M | 8.6% |
26,988
-4,366
| -14% | -$1.76M |
|
2
Abbott
ABT
$231B
| $6.41M | 5.08% |
151,635
+24,383
| +19% | +$1.03M |
|
|
3
Procter & Gamble
PG
$368B
| $4.04M | 3.2% |
45,000
+44,000
| +4,400% | +$3.95M |
|
|
4
Bristol-Myers Squibb
BMY
$96B
| $3.97M | 3.14% |
73,537
+38,462
| +110% | +$2.07M |
|
5
Akebia Therapeutics
AKBA
$833M
| $3.31M | 2.63% |
366,118
-1,158
| -0.3% | -$10.5K |
|
6
Sarepta Therapeutics
SRPT
$1.78B
| $3.01M | 2.39% |
49,025
-11,883
| -20% | -$730K |
|
|
CLVS
7
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.56M | 2.03% |
71,091
+65,901
| +1,270% | +$2.38M |
|
|
OTIC
8
DELISTED
Otonomy, Inc.
OTIC
| $2.53M | 2.01% |
139,085
-53,700
| -28% | -$977K |
|
|
9
iShares Biotechnology ETF
IBB
$5.6B
| $2.03M | 1.61% |
+7,000
| New | +$2.03M |
|
|
MON
10
DELISTED
Monsanto Co
MON
| $1.77M | 1.4% |
+17,313
| New | +$1.77M |
|
11
Ulta Beauty
ULTA
$22.1B
| $1.75M | 1.39% |
+7,362
| New | +$1.75M |
|
12
Humana
HUM
$36.5B
| $1.65M | 1.3% |
9,300
+1,450
| +18% | +$256K |
|
|
POT
13
DELISTED
Potash Corp Of Saskatchewan
POT
| $1.55M | 1.23% |
95,080
-1,000
| -1% | -$16.3K |
|
|
CASC
14
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $1.51M | 1.19% |
917,575
-200,086
| -18% | -$328K |
|
15
Rocket Pharmaceuticals
RCKT
$354M
| $1.49M | 1.18% |
156,864
+12,113
| +8% | +$115K |
|
16
Teva Pharmaceuticals
TEVA
$21.1B
| $1.44M | 1.14% |
+31,300
| New | +$1.44M |
|
17
Puma Biotechnology
PBYI
$254M
| $1.43M | 1.13% |
+21,338
| New | +$1.43M |
|
|
RDUS
18
DELISTED
Radius Health, Inc.
RDUS
| $1.39M | 1.1% |
+25,753
| New | +$1.39M |
|
|
YHOO
19
DELISTED
Yahoo Inc
YHOO
| $1.31M | 1.04% |
30,341
| – | – |
|
20
Gilead Sciences
GILD
$140B
| $1.3M | 1.03% |
16,421
+11,531
| +236% | +$912K |
|
21
Walmart
WMT
$774B
| $1.28M | 1.02% |
+17,771
| New | +$1.28M |
|
22
United Therapeutics
UTHR
$13.8B
| $1.25M | 0.99% |
+10,566
| New | +$1.25M |
|
|
KITE
23
DELISTED
Kite Pharma, Inc.
KITE
| $1.18M | 0.94% |
+21,134
| New | +$1.18M |
|
24
Starbucks
SBUX
$100B
| $1.14M | 0.91% |
+21,100
| New | +$1.14M |
|
|
CMRX
25
DELISTED
Chimerix, Inc.
CMRX
| $1.14M | 0.9% |
205,266
-15,000
| -7% | -$83.1K |
|